{"id":"https://openalex.org/W2034466321","doi":"https://doi.org/10.1016/j.coph.2005.10.002","title":"GABAB receptor: a site of therapeutic benefit","display_name":"GABAB receptor: a site of therapeutic benefit","publication_year":2005,"publication_date":"2005-12-20","ids":{"openalex":"https://openalex.org/W2034466321","doi":"https://doi.org/10.1016/j.coph.2005.10.002","mag":"2034466321","pmid":"https://pubmed.ncbi.nlm.nih.gov/16361115"},"language":"en","primary_location":{"id":"doi:10.1016/j.coph.2005.10.002","doi":"https://doi.org/10.1016/j.coph.2005.10.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.coph.2005.10.002","pdf_url":null,"source":{"id":"https://openalex.org/S13215328","display_name":"Current Opinion in Pharmacology","issn_l":"1471-4892","issn":["1471-4892","1471-4973"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2034466321"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081986132","display_name":"Norman George Bowery","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"N BOWERY","raw_affiliation_strings":["GlaxoSmithKline, Verona Biology, Psychiatry Centre of Excellence for Drug Discovery - Psychiatry, Via A Fleming 4, 37135 Verona, Italy. Norman.2.Bowery@GSK.com","GlaxoSmithKline, Verona Biology, Psychiatry Centre of Excellence for Drug Discovery - Psychiatry, Via A Fleming 4, 37135 Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Verona Biology, Psychiatry Centre of Excellence for Drug Discovery - Psychiatry, Via A Fleming 4, 37135 Verona, Italy. Norman.2.Bowery@GSK.com","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"GlaxoSmithKline, Verona Biology, Psychiatry Centre of Excellence for Drug Discovery - Psychiatry, Via A Fleming 4, 37135 Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5081986132"],"corresponding_institution_ids":["https://openalex.org/I4210128413"],"apc_list":{"value":3510,"currency":"USD","value_usd":3510},"apc_paid":null,"fwci":4.2464,"has_fulltext":false,"cited_by_count":241,"citation_normalized_percentile":{"value":0.95553558,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"6","issue":"1","first_page":"37","last_page":"43"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gabab-receptors","display_name":"GABAB receptors","score":0.9390000104904175},{"id":"https://openalex.org/keywords/baclofen","display_name":"baclofen","score":0.984000027179718},{"id":"https://openalex.org/keywords/gabab-receptor-antagonists","display_name":"GABAB receptor antagonists","score":0.8410000205039978},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.8420000076293945},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.5170000195503235},{"id":"https://openalex.org/keywords/receptor-pharmacology","display_name":"receptor pharmacology","score":0.4869999885559082},{"id":"https://openalex.org/keywords/preclinical-research","display_name":"preclinical research","score":0.3840000033378601}],"concepts":[{"id":"https://openalex.org/C101027131","wikidata":"https://www.wikidata.org/wiki/Q305671","display_name":"GABAB receptor","level":4,"score":0.9441096782684326},{"id":"https://openalex.org/C2781201050","wikidata":"https://www.wikidata.org/wiki/Q413717","display_name":"Baclofen","level":4,"score":0.8303312063217163},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.6609569191932678},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6304665207862854},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5213900208473206},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4239000082015991},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3762407898902893},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.19529882073402405},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.05658063292503357}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001418","descriptor_name":"Baclofen","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001418","descriptor_name":"Baclofen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004832","descriptor_name":"Epilepsy, Absence","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004832","descriptor_name":"Epilepsy, Absence","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009128","descriptor_name":"Muscle Spasticity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009128","descriptor_name":"Muscle Spasticity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009943","descriptor_name":"Organophosphorus Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009943","descriptor_name":"Organophosphorus Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018080","descriptor_name":"Receptors, GABA-B","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D018080","descriptor_name":"Receptors, GABA-B","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018080","descriptor_name":"Receptors, GABA-B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018755","descriptor_name":"GABA Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018755","descriptor_name":"GABA Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018756","descriptor_name":"GABA Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018756","descriptor_name":"GABA Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.coph.2005.10.002","doi":"https://doi.org/10.1016/j.coph.2005.10.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.coph.2005.10.002","pdf_url":null,"source":{"id":"https://openalex.org/S13215328","display_name":"Current Opinion in Pharmacology","issn_l":"1471-4892","issn":["1471-4892","1471-4973"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Pharmacology","raw_type":"journal-article"},{"id":"pmid:16361115","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16361115","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W619973862","https://openalex.org/W1571586310","https://openalex.org/W1654156243","https://openalex.org/W1917556513","https://openalex.org/W1963576726","https://openalex.org/W1969658311","https://openalex.org/W1970693215","https://openalex.org/W1973551643","https://openalex.org/W1976467497","https://openalex.org/W1985387006","https://openalex.org/W1988708221","https://openalex.org/W1994366671","https://openalex.org/W2003506319","https://openalex.org/W2004697417","https://openalex.org/W2009841830","https://openalex.org/W2012925630","https://openalex.org/W2027950087","https://openalex.org/W2029785909","https://openalex.org/W2037618899","https://openalex.org/W2048651523","https://openalex.org/W2052990681","https://openalex.org/W2059633455","https://openalex.org/W2061118494","https://openalex.org/W2063238027","https://openalex.org/W2066214756","https://openalex.org/W2072459855","https://openalex.org/W2076756254","https://openalex.org/W2078800654","https://openalex.org/W2079411172","https://openalex.org/W2080268900","https://openalex.org/W2086013219","https://openalex.org/W2086452840","https://openalex.org/W2087675056","https://openalex.org/W2090890495","https://openalex.org/W2092303082","https://openalex.org/W2110469184","https://openalex.org/W2124517960","https://openalex.org/W2145734582","https://openalex.org/W2155552431","https://openalex.org/W2157230965","https://openalex.org/W2163874819","https://openalex.org/W2165696259","https://openalex.org/W2173778691","https://openalex.org/W2325472161","https://openalex.org/W2418404000","https://openalex.org/W4297819556"],"related_works":["https://openalex.org/W1978839006","https://openalex.org/W4252480168","https://openalex.org/W191580440","https://openalex.org/W4251910876","https://openalex.org/W1558288713","https://openalex.org/W3164019059","https://openalex.org/W2161977773","https://openalex.org/W1979069425","https://openalex.org/W2775313795","https://openalex.org/W2616850498"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":16}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}